MAPT and Alzheimer disease: Tau oligomers and filaments, released following the process of neuronal apoptosis, can further reactivate microglial cells, perpetuating a detrimental molecular signaling cascade that contributes to the ongoing neurodegeneration in Alzheimer’s disease and other tauopathies [31].